Q1: 2026-05-12 Earnings Summary EPS of -$0.14 beats by $0.02  |  Revenue of $8.90M (-2.92% Y/Y) misses by $1.54M TriSalus Life Sciences, Inc. ( TLSI ) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT Company Participants Mary Szela - CEO, President & Director David Patience - Chief Financial Officer Richard Marshall - Medical Director Conference Call Participants Jeremy Feffer - Lifesci Advisors, LLC Frank Takkinen - Lake Street Capital Markets, LLC, Research Division William Plovanic - Canaccord Genuity Corp., Research Division Justin Walsh - JonesTrading Institutional Services, LLC, Research Division Presentation Operator Good afternoon, and welcome to the TriSalus Life Sciences First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I will now turn the call over to Jeremy Feffer, Managing Director with Lifesci Advisors. Please go ahead.…